This world-class facility strengthens its end-to-end CDMO capabilities and enhances its ability to safely develop and test and deliver highly potent compounds for the global pharmaceutical industry.
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements. The lab is purpose-built to support the development of complex oncology and specialty molecules, including components of Antibody Drug Conjugates (ADCs), Peptide Drug Conjugates (PDCs), and Proteolysis Targeting Chimeras (PROTACs).
“Our new HPAPI laboratory represents a critical step forward in expanding our capabilities and reinforcing our unwavering commitment to innovation,safety and customer excellence,” said Sameer Hiremath, Vice Chairman & Managing Director, Hikal Ltd. “With this new addition to our technology toolbox, we are well positioned to meet the growing demand for potent molecule development while maintaining the highest global standards of containment and compliance.”
Key Features of the Facility
Segregated entry and exit for personnel and materials to ensure safe operations
Complete sequence control from raw material dispensing to final packing within isolators
Built-in milling operations to meet precise particle size requirements during development
Advanced analytical capabilities including HPLC and GC for in-lab analysis of HPAPIs, avoiding cross-contamination
Stringent containment systems, maintaining exposure control to OEB 5, validated through independent third-party surrogate testing.
The HPAPI Lab complements Hikal’s existing validation lab, process safety lab, solid state lab, flow chemistry lab, instrumentation and synthesis laboratories.
Established in 1988, Hikal is a partner to companies in the Pharmaceutical, Animal Health, Biotech, Personal Care and Specialty Chemical industries. The company manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology Innovation centre at Pune. Its facilities have been inspected and certified by Global Regulatory Authorities.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.